Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 393,700 shares, a growth of 666.0% from the July 31st total of 51,400 shares. Approximately 12.5% of the company’s shares are short sold. Based on an average trading volume of 544,900 shares, the days-to-cover ratio is presently 0.7 days.
Entero Therapeutics Trading Up 0.9 %
Shares of Entero Therapeutics stock opened at $0.44 on Wednesday. The stock’s 50-day simple moving average is $0.88. Entero Therapeutics has a 1-year low of $0.19 and a 1-year high of $22.20. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.21 and a quick ratio of 1.21.
About Entero Therapeutics
Further Reading
- Five stocks we like better than Entero Therapeutics
- Options Trading – Understanding Strike Price
- Akamai: AI Tailwinds Drive Edge Computing and Security Growth
- About the Markup Calculator
- DoorDash Stock Sprints Higher on EPS Beat and Raised Guidance
- Trading Stocks: RSI and Why it’s Useful
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.